This invention relates to stabilizing adjacent vertebrae of the spine by inserting an intervertebral spacer, and more particularly an intervertebral spacer that is adjustable in height, and a tool therefore.
The vertebral or spinal column (spine, backbone) is a flexible assembly of vertebrae stacked on top of each other extending from the skull to the pelvic bone which acts to support the axial skeleton and to protect the spinal cord and nerves. The vertebrae are anatomically organized into four generalized body regions identified as cervical, thoracic, lumbar, and sacral; the cervical region including the top of the spine beginning in the skull, the thoracic region spanning the torso, the lumbar region spanning the lower back, and the sacral region including the base of the spine ending with connection to the pelvic bone. With the exception of the first two cervical vertebrae, cushion-like discs separate adjacent vertebrae, i.e. intervertebral discs.
The stability of the vertebral column during compression and movement is maintained by the intervertebral discs. Each disc includes a gel-like center surrounded by a fibrous ring. The gel-like center, i.e. nucleus pulposus, provides strength such that the disc can absorb and distribute external loads and contains a mixture of type II-collagen dispersed in a proteoglycan matrix. The fibrous ring, or annulus fibrosus, provides stability during motion and contains laminated rings of type-I collagen. Thus, the annulus fibrosis and the nucleus pulposus are interdependent, as the annulus fibrosis contains the nucleus pulposus in place and the nucleus pulposus aligns the annulus fibrosus to accept and distribute external loads. The integrity of the composition and structure of the intervertebral disc is necessary to maintain normal functioning of the intervertebral disc.
Many factors can adversely alter the composition and structure of the intevertebral disc, such as normal physiological aging, mechanical injury/trauma, and/or disease, resulting in impairment or loss of disc function. For example, the content of proteoglycan in the nucleus pulposus declines with age, thus, it follows that the ability of the nucleus pulposus to absorb water concurrently declines. Therefore, in normal aging the disc progressively dehydrates, resulting in a decrease in disc height and possible de-lamination of the annulus fibrosus. Mechanical injury can tear the annulus fibrosis allowing the gel-like material of the nucleus pulposus to extrude into the spinal canal and compress neural elements. Growth of a spinal tumor can impinge upon the vertebrae and/or disc potentially compressing nerves.
Bones of the spine, and bony structures, generally, are susceptible to a variety of weaknesses that can affect their ability to provide support and structure. Weaknesses in bony structures have numerous potential causes, including degenerative diseases, tumors, fractures, and dislocations. Advances in medicine and engineering have provided doctors with a plurality of devices and techniques for alleviating or curing these weaknesses.
In some cases, the spinal column, in particular, requires additional support in order to address such weaknesses. One technique for providing support is to insert a spacer between adjacent vertebrae.
In accordance with an embodiment of the disclosure, a spacer for separating bones of a joint comprises a frame; a carriage slideably moveable in relation to the frame, and having at least one ramped surface; an actuating screw connected to the carriage and supported by the frame, the actuating screw configured to cause the carriage to slideably move in relation to the frame when the actuating screw is rotated; a first endplate configured to engage a first bone of the joint, and having at least one ramped surface mateable with the at least one carriage ramped surface, whereby when the carriage is slideably moved by rotation of the actuating screw, the at least one endplate ramped surface slides against the at least one carriage ramped surface to cause the first endplate to move along an axis transverse to the longitudinal axis, to increase a height of the spacer; and a second endplate configured to engage a second bone of the joint.
In various embodiments thereof, the carriage includes a threaded bore into which the actuating screw is threaded; the endplate is continuously curved along its length; the actuating screw is secured to the carriage by a nut; the nut and the carriage form a mating, curved bearing surface therebetween; the spacer further includes a screw support connected to the frame and configured to rotatably retain the actuating screw; the screw support forms a longitudinal axis, and the frame forms a longitudinal axis, the screw support being slideably connected to the frame to enable changing an angular orientation between the actuating screw and the frame.
In other embodiments thereof, the screw is rotatable at a plurality of angular orientations of the actuating screw and the frame; the screw support is slideably connected to the frame by a flanged connection; the first endplate is connected to the frame by a slideable flanged connection.
In another embodiment thereof, the spacer further includes a pin moveable within a slot formed in the carriage; and a link pivotably mounted to the pin, and including a threaded bore into which the actuating screw is threadably engageable to cause the carriage to slideably move within the frame.
In yet further embodiments thereof, the first endplate is slideably retained in connection with the frame by a flanged connection; the spacer further includes a screw support pivotally connected to the frame and rotatably supporting the actuating screw; the carriage includes at least two ramped surfaces, and the second endplate includes at least one ramped surface mateable with at least one of the at least two ramped surfaces of the carriage, whereby when the carriage is slideably moved by rotation of the actuating screw, the at least one second endplate ramped surface slides against the at least one additional carriage ramped surface to cause the second endplate to move along an axis transverse to the longitudinal axis to increase a height of the spacer.
In other embodiments thereof, the first endplate is configured to abut the frame as the first endplate is moved along an axis transverse to the longitudinal axis, whereby the first endplate moves substantially only along an axis transverse to the longitudinal axis; at least one of the first endplate and the frame includes at least one aperture through which a fastener may pass to secure the spacer to a bone of the joint; the spacer further includes a blocking mechanism to prevent backing out of a fastener passed through the first endplate; the first endplate includes one or more projections configured to engage bone of the joint when the implant is positioned between bones of the joint.
In another embodiment of the disclosure, a method of separating bones of a joint comprises inserting a spacer between bones of the joint, the spacer including a frame; a carriage slideably moveable in relation to the frame, and having at least one ramped surface; an actuating screw connected to the carriage and supported by the frame, the actuating screw configured to cause the carriage to slideably move in relation to the frame when the actuating screw is rotated; a first endplate configured to engage a first bone of the joint, and having at least one surface mateable with the at least one carriage ramped surface, whereby when the carriage is slideably moveable by rotation of the actuating screw, the at least one endplate ramped surface slides against the at least one carriage ramped surface to cause the first endplate to move along an axis transverse to the longitudinal axis, to increase a height of the spacer; and a second endplate configured to engage a second bone of the joint.
In a yet further embodiment of the disclosure, a spacer for separating bones of a joint comprises a frame; a carriage slideably moveable in relation to the frame, and having at least two ramped surfaces; a screw support moveably connected to the frame to form a changeable angular orientation with respect to the frame; an actuating screw supported by the screw support and connected to the carriage, the actuating screw configured to cause the carriage to slideably move in relation to the frame when the actuating screw is rotated; and first and second endplates each configured to engage an opposing bone of the joint, each having at least one ramped surface mateable with at least one of the at least two carriage ramped surfaces, whereby when the carriage is slideably moved by rotation of the actuating screw, the at least one ramped surface of each of the first and second endplates slides against the at least one carriage ramped surface to cause the first and second endplates to move relatively apart along an axis transverse to the longitudinal axis, to increase a height of the spacer.
A more complete understanding of the disclosure, and the attendant advantages and features thereof, will be more readily understood by reference to the following detailed description when considered in conjunction with the accompanying drawings, in which:
As required, detailed embodiments are disclosed herein; however, it is to be understood that the disclosed embodiments are merely examples and that the systems and methods described below can be embodied in various forms. Therefore, specific structural and functional details disclosed herein are not to be interpreted as limiting, but merely as a basis for the claims and as a representative basis for teaching one skilled in the art to variously employ the present subject matter in virtually any appropriately detailed structure and function. Further, the terms and phrases used herein are not intended to be limiting, but rather, to provide an understandable description of the concepts.
The terms “a” or “an”, as used herein, are defined as one or more than one. The term plurality, as used herein, is defined as two or more than two. The term another, as used herein, is defined as at least a second or more. The terms “including” and “having,” as used herein, are defined as comprising (i.e., open language).
With reference to
The implant and methods for its insertion can be used in a treatment protocol for any of a wide variety of conditions in a patient involving diseased or damaged bony structures. The patient can be a human being. Additionally, it is contemplated that the implant may be useful in veterinary science for any animal having adjacent bony structures to be fused. The implant can collapse, for example, to approximately one half of an expanded size. When in this collapsed configuration, the implant can be inserted into a space through a small incision and narrow pathways, using appropriate minimally-invasive techniques, and can be positioned within the space between adjacent bones, and there expanded to a desired therapeutic height. The incision may be short, for example about one inch in length, which is smaller than the implant in an expanded configuration. If the desired position and/or expansion are not achieved, the implant can be collapsed, repositioned, and re-expanded in situ.
Although the implant is exemplified herein for use in the spine, the implant is contemplated for fusion of any bony structures. While the implants are described herein using several varying embodiments, the implants are not limited to these embodiments. An element of one embodiment may be used in another embodiment, or an embodiment may not include all described elements.
With reference to
Spacer 100 forms a distal end 154 which is inserted first into the body, and which can be tapered to facilitate insertion between body tissue, and a proximal end 156, to which a tool may be connected. Distal and proximal ends 154 and 156 define a longitudinal plane 158, extending therebetween. To expand Spacer 100, lift ramps 250 are displaced relative to endplates 102, 104, causing expansion ramps 150 to slide along lift ramps 250, thereby moving endplates 102, 104 relatively apart, thereby increasing a height of Spacer 100. Body tissue engaging projections 152, for example tooth shaped projections, can be provided upon a surface of endplate 102, 104, to further secure spacer 100 in a therapeutic location.
Lift ramps 250 extend from carriage 200, which is slideably retained within a frame 126 extending between endplates 102, 104. Carriage 200 is displaced relative to endplates 102, 104 by being pulled by a pin 106 connected to a link 108 threadably connected to an actuating screw 110. One or more guide elements 112, associated with frame 126, can be provided to prevent endplates 102, 104 from moving along longitudinal axis 158 along with carriage 200, thereby causing lift ramps 250 and expansion ramps 150 to be moved relative to each other, expanding or contracting Spacer 100. Actuating screw can be prevented from moving along longitudinal axis by a blocking flange 114 or 174.
With further reference to
In one embodiment, a path of travel of screw support 160 is defined by connection 162 to maintain a fixed orientation of carriage 200 with respect to frame 126. More particularly, if screw support 160 is moved along a path which does not pivot about a single point defined by a current location of pin 106, pin 106 may move within slot 202 to maintain a fixed distance in a contracted position between pin 106 and screw support 160, and therefore carriage 200 is not caused to be moved as screw support 160 is moved. In other embodiments, slot 202 is defined to cause a predetermined movement of carriage 200 as screw support 160 is moved.
Similarly, regardless of a given orientation of screw support 160, rotation of actuating screw advances or retards link 108 and pin 106, causing movement of carriage 200 relative to endplates 102, 104. More particularly, slot 202 defines a longitudinal axis 268, which is oriented to lie at a non-perpendicular angle ((3) with respect to longitudinal axis 168 of screw support 160, through a substantial portion of the range of motion of screw support 160. In this manner, once a desired orientation of screw support 160 has been established, rotation of actuating screw 110 causes pin 106 to push or pull along an edge of slot 202, thereby causing movement of carriage 200. If axis 168 and 268 are perfectly perpendicular, it is possible no movement can be caused by threading screw 110; however, as a practical matter, reorienting screw support 160 a very small amount can resolve this theoretical limitation. Carriage 200 is slideably retained by a channel or edge interface 116 formed between carriage 200 and at least one endplate 102, 104, thereby limiting movement of carriage 200 along longitudinal axis 158.
With reference to
As may be seen in
Turning now to
As actuating screw 110B threads into carriage 200B, shaft 140 and head 142 of screw 110B are angularly displaced with respect to screw support 160B. Accordingly, screw support 160B is provided with a gapped region 170, allowing movement of screw 110B. Additionally, screw support 160B is retained in connection with a frame 126B by a flanged connection 162B, in this case a dovetail connection. Connection 162B enables screw support 160B to be angled with respect to frame 126B, to facilitate access to screw 110B by a tool (not shown), when spacer 100B is implanted within the body, and to further enable screw 110B to change an angle with respect to frame 126B.
Frame 126B is connected to each of endplates 102B, 104B by a flanged connector, in this embodiment a dovetail formed between endplate flanges 178 extending from each of endplates 102B, 104B, and frame flanges 180 associated with an intermediate connector 182. Actuating screw 110B can be rotatably retained within screw support 160B by a washer or flange (not shown) positioned in groove 186 within screw support 160B, or intermediate connector 182 can be configured to rotatably retain screw 100B.
With reference to
As may best be seen in
The following discussion pertains to all embodiments of the disclosure, including spacers 100, 100A, 100B, and 100C. For brevity, the letter suffix designating variations of like parts will be omitted, unless a specific distinction is made. For all spacer 100 embodiments of the disclosure, carriage 200 can be slid, or actuated, when screw support 60 is disposed at an angle with respect to the carriage. In the embodiments of
In all embodiments, head 142 of screw 110 may be accessed by a driving tool extending from outside the body, into the body, while endplates 102, 104 lie at an angle, for example perpendicular, to a pathway into the body. More particularly, spacers 100 of the disclosure may be inserted between vertebral bodies when in a collapsed or non-expanded state, from any approach to the spine. As spacer 100 is inserted between endplates, it is rotated to contact cortical bone of the endplates, and to avoid anatomical structures which should not be disturbed.
Once rotated into position, screw support 160 can be turned towards an exterior of the body, if it has not already been so turned, whereby a tool may be conveniently mated with a tool engagement 188 of screw head 142. After screw 110 is rotated, endplates 102, 104 separate, expanding or increasing a height of spacer 100, and restoring and maintaining a therapeutic spacing between adjacent bones. In some embodiments, after expansion of spacer 100, screw support 160 may slide along flanged connection 162 to lie at an optimal orientation with respect to body tissue, for example 0 degrees with respect to carriage 200, or at an angle deemed best by the medical practitioner.
Spacers 100 may include ramps 150, 250 of differing height within a spacer, whereby endplates 102, 104 mutually separate at different rates at distal and proximal ends 154, 156, or at sides transverse to distal and proximal ends 154, 156, whereby an angular disposition of adjacent bones may be changed, for example to correct lordosis or scoliosis. Endplates 102, 104 may additionally, or alternatively, be resilient, so that they may conform to bony surfaces, forming a more stable support platform. Accordingly, endplates 102, 104 can be fabricated from a polymeric material, a naturally resilient material, or a resilient metal, for example a shape memory alloy, or any other resilient biocompatible material of sufficient strength and durability for separating bones within the body. Spacers 100 may further be removed or repositioned during an initial implantation procedure, or later in time.
In accordance with the disclosure, during implantation of intervertebral spacers from a posterior approach, there is a need to avoid damaging nerve roots. A prior art spacer dimensioned to separate bones can block a view of nerve roots as it is inserted, and due to its large size, poses a greater risk of contacting nerve roots during insertion into the body. As a result, the medical practitioner must more often retract nerve roots, with attendant danger of tissue damage. Spacers 100 of the disclosure form a smaller dimension during implantation, relative to a final dimension for spacing bones. Accordingly, nerve roots can be visualized and avoided during insertion, and nerve root manipulation can be avoided or minimized.
As spacers 100 of the disclosure can be articulated during implantation, they can be inserted between bones by being passed through a minimally invasive entry, for example through an incision approximating the smallest collapsed dimension, for example transverse to a longitudinal dimension extending between distal and proximal ends 154, 156. This enables exceptional anterior placement without impaction, as well as facilitating implantation from other approaches. Implants of the disclosure further develop a good bone contact area, as an implant with a larger footprint may be inserted through a reduced size incision, due to the overall dimensions of the implant being reduced during insertion.
Spacers 100 of the disclosure enable a continuous expansion and retraction over a range of displacements according to predetermined dimensions of a specific spacer design. This provides the ability to distract vertebral bodies or other bones to a desired height or separation. Endplates 102, 104 can be shaped to form planes or surfaces which converge relative to each, to provide for proper lordosis, and can be provided with openings 190 through which bone may grow, and into which bone graft material may be placed. Spacers 100 of the disclosure may be used to distract, or force bones of a joint apart, or may be used to maintain a separation of bones created by other means, for example by a retractor. Endplates may additionally be curved to conform to the surface of body tissue, for example the surface of cortical bone, of the vertebra to be contacted, for improved fixation and load bearing.
Spacers 100 of the disclosure may be further secured in connection with the body by passage of elongated fasteners through frame 162, or an endplate 102, 104. As described therein, a blocking mechanism can be used to prevent backing out of the elongated fastener. Similarly, screw 110 can be provided with a blocking mechanism as described in the foregoing reference, or a resilient washer (not shown) may be positioned within groove 186, to resist unintended rotation of screw 110.
Implants of the disclosure may be fabricated using any biocompatible materials known or hereinafter discovered, having sufficient strength, flexibility, resiliency, and durability for the patient, and for the term during which the device is to be implanted. Examples include but are not limited to metal, such as, for example titanium and chromium alloys; polymers, including for example, PEEK or high molecular weight polyethylene (HMWPE); and ceramics. There are many other biocompatible materials which may be used, including other plastics and metals, as well as fabrication using living or preserved tissue, including autograft, allograft, and xenograft material.
Portions or all of the implant may be radiopaque or radiolucent, or materials having such properties may be added or incorporated into the implant to improve imaging of the device during and after implantation.
Spacers 100 may be formed using titanium, or a cobalt-chrome-molybdenum alloy, Co—Cr—Mo, for example as specified in ASTM F1537 (and ISO 5832-12). The smooth surfaces may be plasma sprayed with commercially pure titanium, as specified in ASTM F1580, F1978, F1147 and C-633 (and ISO 5832-2). Alternatively, part or all of spacers 100 may be formed with a polymer, for example ultra-high molecular weight polyethylene, UHMWPE, for example as specified in ASTM F648 (and ISO 5834-2). In one embodiment, PEEK-OPTIMA (a trademark of Invibio Ltd Corp, United Kingdom) may be used for one or more components of the implants of the disclosure. For example, polymeric portions can be formed with PEEK-OPTIMA, which is radiolucent, whereby bony ingrowth may be observed. Other polymeric materials with suitable flexibility, durability, and biocompatibility may also be used.
In accordance with the invention, implants of various sizes may be provided to best fit the anatomy of the patient. Components of matching or divergent sizes may be assembled during the implantation procedure by a medical practitioner as best meets the therapeutic needs of the patient, the assembly inserted within the body using an insertion tool. Implants of the invention may also be provided with an overall angular geometry, for example an angular mating disposition of endplates, to provide for a natural lordosis, or a corrective lordosis, for example of from 0° to 12° for a cervical application, although much different values may be advantageous for other joints. Lordotic angles may also be formed by shaping one or both endplates to have relatively non-coplanar surfaces.
Expanded implant heights, for use in the cervical vertebrae for example, may typically range from 7 mm to 12 mm, but may be larger or smaller, including as small as 5 mm, and as large as 16 mm, although the size is dependent on the patient, and the joint into which an implant of the invention is to be implanted. Spacers 100 may be implanted within any level of the spine, and may also be implanted in other joints of the body, including joints of the hand, wrist, elbow, shoulder, hip, knee, ankle, or foot.
In accordance with the invention, a single spacer 100 may be used, to provide stabilization for a weakened joint or joint portion. Alternatively, a combination of two, three, or more of any of spacer 100 may be used, at a single joint level, or in multiple joints. Moreover, implants of the disclosure may be combined with other stabilizing means.
Additionally, spacers 100 of the disclosure may be fabricated using material that biodegrades in the body during a therapeutically advantageous time interval, for example after sufficient bone ingrowth has taken place. Further, implants of the disclosure are advantageously provided with smooth and or rounded exterior surfaces, which reduce a potential for deleterious mechanical effects on neighboring tissues.
Any surface or component of an implant of the disclosure may be coated with or impregnated with therapeutic agents, including bone growth, healing, antimicrobial, or drug materials, which may be released at a therapeutic rate, using methods known to those skilled in the art.
Devices of the disclosure provide for adjacent vertebrae to be supported during flexion/extension, lateral bending, and axial rotation. In one embodiment, spacer 100 is indicated for spinal arthroplasty in treating skeletally mature patients with degenerative disc disease, primary or recurrent disc herniation, spinal stenosis, or spondylosis in the lumbosacral spine (LI-ST). Degenerative disc disease is advantageously defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies, with or without leg (radicular) pain. Patients are advantageously treated, for example, who may have spondylolisthesis up to Grade 1 at the involved level. The surgery position spacer 100 may be performed through an Anterior, Anterolateral, Posterolateral, lateral or any approach.
In a typical embodiment, spacer implants of the disclosure have an uncompressed height, before insertion, of 7 to 13 mm, and may advantageously be provided in cross-sections of 10×27 mm, 12×32 mm and 12×37 mm, with 4, 8, 12, or 16 degree lordotic angles, although these are only representative sizes, and substantially smaller or larger sizes can be therapeutically beneficial. In one embodiment implants in accordance with the instant disclosure are sized to be inserted using an MIS approach, for example using a reduced incision size, for example less than about 5 cm, and advantageously less than about 2.5 cm, with fewer and shorter cuts through body tissue. Spacer 100 may advantageously be used in combination with other known or hereinafter developed forms of stabilization or fixation, including for example rods and plates.
Spacer implants of the disclosure can be inserted into the body, advantageously in a contracted or non-expanded configuration, through a transforaminal approach, and can articulate in attachment to an inserter tool (not shown), for example for anterior placement. Once placement is achieved, the implant is capable of expanding for disc height restoration. To maintain an engagement spacer 100 and an insertion tool, a driving end (not shown) of the tool is inserted into tool engagement 188. To prevent separation of the tool and spacer 100, a tool connector 192 may be provided, extending from or formed within screw support 60. In the embodiment shown in
Portions of spacer 100 may be radiopaque or radiotransparent. To improve visibility under imaging, radiopaque elements 194 may be provided in predetermined locations within spacer 100. In the embodiment of
Implant spacers 100 of the disclosure can be positioned anterioriorly and continuously expanded to provide axial balance and greater endplate contact area, and allow for superior sagittal correction, and are insertable into the body through a smaller window, decreasing the need for damage and trauma to body tissue. Spacers 100 of disclosure provide the benefits of an ALIF device, implantable through a familiar posterior approach, decreasing surgery time and associated blood loss, as well as eliminating the need for an access surgeon.
All references cited herein are expressly incorporated by reference in their entirety. There are many different features to the present invention and it is contemplated that these features may be used together or separately. Unless mention was made above to the contrary, it should be noted that all of the accompanying drawings are not to scale. Thus, the invention should not be limited to any particular combination of features or to a particular application of the invention. Further, it should be understood that variations and modifications within the spirit and scope of the invention might occur to those skilled in the art to which the invention pertains. Accordingly, all expedient modifications readily attainable by one versed in the art from the disclosure set forth herein that are within the scope and spirit of the present invention are to be included as further embodiments of the present invention.
The present application is a continuation of U.S. patent application Ser. No. 14/929,569 filed on Nov. 2, 2015, which is a continuation of U.S. patent application Ser. No. 13/782,724, filed on Mar. 1, 2013, which is incorporated by reference in its entirety herein.
Number | Name | Date | Kind |
---|---|---|---|
4349921 | Kuntz | Sep 1982 | A |
4599086 | Doty | Jul 1986 | A |
4863476 | Shepperd | Sep 1989 | A |
4863477 | Monson | Sep 1989 | A |
5123926 | Pisharodi | Jun 1992 | A |
5290312 | Kojimoto et al. | Mar 1994 | A |
5306310 | Siebels | Apr 1994 | A |
5375823 | Navas | Dec 1994 | A |
5390683 | Pisharodi | Feb 1995 | A |
5522899 | Michelson | Jun 1996 | A |
5534030 | Navarro et al. | Jul 1996 | A |
5554191 | Lahille et al. | Sep 1996 | A |
5571192 | Schonhoffer | Nov 1996 | A |
5645596 | Kim | Jul 1997 | A |
5653763 | Errico et al. | Aug 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5676701 | Yuan et al. | Oct 1997 | A |
5865848 | Baker | Feb 1999 | A |
6039761 | Li et al. | Mar 2000 | A |
6045579 | Hochschuler et al. | Apr 2000 | A |
6080193 | Hochschuler et al. | Jun 2000 | A |
6099531 | Bonutti | Aug 2000 | A |
6126689 | Brett | Oct 2000 | A |
6176882 | Biedermann et al. | Jan 2001 | B1 |
6258125 | Paul et al. | Jul 2001 | B1 |
6558423 | Michelson | May 2003 | B1 |
6562074 | Gerbec et al. | May 2003 | B2 |
6576016 | Hochschuler et al. | Jun 2003 | B1 |
6554863 | Paul et al. | Aug 2003 | B2 |
6641614 | Wagner et al. | Nov 2003 | B1 |
6648917 | Gerbec et al. | Nov 2003 | B2 |
6666891 | Boehm, Jr. et al. | Dec 2003 | B2 |
6692495 | Zacouto | Feb 2004 | B1 |
6706070 | Wagner et al. | Mar 2004 | B1 |
6752832 | Ulrich | Jun 2004 | B2 |
6814756 | Michelson | Nov 2004 | B1 |
6830589 | Erickson | Dec 2004 | B2 |
6849093 | Michelson | Feb 2005 | B2 |
6852129 | Gerbec et al. | Feb 2005 | B2 |
6863673 | Gerbec et al. | Mar 2005 | B2 |
6881228 | Zdeblick et al. | Apr 2005 | B2 |
7018415 | McKay | Mar 2006 | B1 |
7070598 | Lim et al. | Jul 2006 | B2 |
7204853 | Gordon | Apr 2007 | B2 |
7217291 | Zucherman et al. | May 2007 | B2 |
7282063 | Cohen et al. | Oct 2007 | B2 |
7316714 | Gordon | Jan 2008 | B2 |
7473276 | Aebi et al. | Jan 2009 | B2 |
7547325 | Biedermann et al. | Jun 2009 | B2 |
7621953 | Braddock, Jr. et al. | Nov 2009 | B2 |
7641693 | Gutlin et al. | Jan 2010 | B2 |
7682396 | Beaurain et al. | Mar 2010 | B2 |
7749270 | Peterman | Jul 2010 | B2 |
7753958 | Gordon | Jul 2010 | B2 |
7771473 | Thramann | Aug 2010 | B2 |
7780732 | Abernathie | Aug 2010 | B2 |
7799081 | McKinley | Sep 2010 | B2 |
7815683 | Melkent et al. | Oct 2010 | B2 |
7837734 | Zucherman et al. | Nov 2010 | B2 |
7875078 | Wysocki et al. | Jan 2011 | B2 |
7901409 | Canaveral et al. | Mar 2011 | B2 |
7909869 | Gordon | Mar 2011 | B2 |
7909876 | Dooris et al. | Mar 2011 | B2 |
7951199 | Miller | May 2011 | B2 |
7985256 | Grotz et al. | Jul 2011 | B2 |
8062375 | Glerum | Nov 2011 | B2 |
8070813 | Grotz et al. | Dec 2011 | B2 |
8123810 | Gordon | Feb 2012 | B2 |
8137405 | Kostuik et al. | Mar 2012 | B2 |
8192495 | Simpson et al. | Jun 2012 | B2 |
8211178 | Melkent et al. | Jul 2012 | B2 |
8303663 | Jimenez et al. | Nov 2012 | B2 |
8377140 | DeFalco et al. | Feb 2013 | B2 |
8394129 | Lopez et al. | Mar 2013 | B2 |
8394143 | Grotz et al. | Mar 2013 | B2 |
8435296 | Kadaba et al. | May 2013 | B2 |
8454695 | Grotz et al. | Jun 2013 | B2 |
8647386 | Gordon | Feb 2014 | B2 |
8696751 | Ashley et al. | Apr 2014 | B2 |
8771360 | Jimenez et al. | Jul 2014 | B2 |
8894710 | Simpson et al. | Nov 2014 | B2 |
8900305 | Stad et al. | Dec 2014 | B2 |
8932355 | Grotz et al. | Jan 2015 | B2 |
8940049 | Jimenez et al. | Jan 2015 | B1 |
8956413 | Ashley et al. | Feb 2015 | B2 |
8992620 | Ashley et al. | Mar 2015 | B2 |
9028550 | Shulock et al. | May 2015 | B2 |
9358125 | Jlmenez et al. | Jun 2016 | B2 |
9532883 | McLuen et al. | Jan 2017 | B2 |
9622878 | Grotz | Apr 2017 | B2 |
20020045945 | Liu | Apr 2002 | A1 |
20020068976 | Jackson | Jun 2002 | A1 |
20020068977 | Jackson | Jun 2002 | A1 |
20030176926 | Boehm et al. | Sep 2003 | A1 |
20040030387 | Landry et al. | Feb 2004 | A1 |
20040049271 | Biedermann | Mar 2004 | A1 |
20040054412 | Gerbec et al. | Mar 2004 | A1 |
20040087947 | Lim et al. | May 2004 | A1 |
20040153065 | Lim | Aug 2004 | A1 |
20050021041 | Michelson | Jan 2005 | A1 |
20050021145 | de Villiers et al. | Jan 2005 | A1 |
20050033432 | Gordon | Feb 2005 | A1 |
20050080422 | Otte et al. | Apr 2005 | A1 |
20050113916 | Branch | May 2005 | A1 |
20050149188 | Cook | Jul 2005 | A1 |
20050171541 | Boehm | Aug 2005 | A1 |
20050209698 | Gordon et al. | Sep 2005 | A1 |
20050251258 | Jackson | Nov 2005 | A1 |
20050273171 | Gordon | Dec 2005 | A1 |
20050273174 | Gordon | Dec 2005 | A1 |
20050278026 | Gordon | Dec 2005 | A1 |
20050283244 | Gordon | Dec 2005 | A1 |
20050283245 | Gordon | Dec 2005 | A1 |
20060004453 | Bartish et al. | Jan 2006 | A1 |
20060015184 | Winterbottom et al. | Jan 2006 | A1 |
20060058878 | Michelson | Mar 2006 | A1 |
20060084986 | Grinberg et al. | Apr 2006 | A1 |
20060122701 | Kister | Jun 2006 | A1 |
20060129244 | Ensign | Jun 2006 | A1 |
20060142859 | Mcluen | Jun 2006 | A1 |
20060149385 | Mckay | Jul 2006 | A1 |
20060195192 | Gordon et al. | Aug 2006 | A1 |
20060229729 | Gordon | Oct 2006 | A1 |
20060241770 | Rhoda et al. | Oct 2006 | A1 |
20060253201 | Mcluen | Nov 2006 | A1 |
20070043442 | Abernathie | Feb 2007 | A1 |
20070050030 | Kim | Mar 2007 | A1 |
20070050032 | Gittings et al. | Mar 2007 | A1 |
20070055377 | Hanson et al. | Mar 2007 | A1 |
20070191951 | Branch | Aug 2007 | A1 |
20070255415 | Edie et al. | Nov 2007 | A1 |
20070270963 | Melkent et al. | Nov 2007 | A1 |
20070270968 | Baynham | Nov 2007 | A1 |
20080021559 | Thramann | Jan 2008 | A1 |
20080065222 | Hamada | Mar 2008 | A1 |
20080114467 | Capote et al. | May 2008 | A1 |
20080140207 | Olmos et al. | Jun 2008 | A1 |
20080147193 | Matthis | Jun 2008 | A1 |
20080147194 | Grotz et al. | Jun 2008 | A1 |
20080161933 | Grotz et al. | Jul 2008 | A1 |
20080167657 | Greenhalgh | Jul 2008 | A1 |
20080183204 | Greenhalgh et al. | Jul 2008 | A1 |
20080221694 | Warnick et al. | Sep 2008 | A1 |
20080275455 | Berry et al. | Nov 2008 | A1 |
20080281346 | Greenhalgh et al. | Nov 2008 | A1 |
20080288073 | Renganath et al. | Nov 2008 | A1 |
20080300598 | Barreiro et al. | Dec 2008 | A1 |
20080306488 | Altarac et al. | Dec 2008 | A1 |
20080319487 | Fielding et al. | Dec 2008 | A1 |
20080319549 | Greenhalgh et al. | Dec 2008 | A1 |
20090024217 | Levy et al. | Jan 2009 | A1 |
20090062833 | Song | Mar 2009 | A1 |
20090076616 | Duggal et al. | Mar 2009 | A1 |
20090125062 | Arnin | May 2009 | A1 |
20090149956 | Greenhalgh et al. | Jun 2009 | A1 |
20090149959 | Conner et al. | Jun 2009 | A1 |
20090204218 | Richelsoph | Aug 2009 | A1 |
20090222100 | Cipoletti et al. | Sep 2009 | A1 |
20090240334 | Richelsoph | Sep 2009 | A1 |
20090270989 | Conner et al. | Oct 2009 | A1 |
20090281628 | Oglaza et al. | Nov 2009 | A1 |
20090292361 | Lopez | Nov 2009 | A1 |
20090299478 | Carls et al. | Dec 2009 | A1 |
20090312763 | McCormack | Dec 2009 | A1 |
20100049324 | Valdevit | Feb 2010 | A1 |
20100070041 | Peterman | Mar 2010 | A1 |
20100082109 | Greenhalgh et al. | Apr 2010 | A1 |
20100145455 | Simpson et al. | Jun 2010 | A1 |
20100179657 | Greenhalgh et al. | Jul 2010 | A1 |
20100211176 | Greenhalgh | Aug 2010 | A1 |
20100222816 | Gabelberger et al. | Sep 2010 | A1 |
20100286783 | Lechmann et al. | Nov 2010 | A1 |
20110035011 | Cain | Feb 2011 | A1 |
20110093074 | Glerum et al. | Apr 2011 | A1 |
20110160861 | Jimenez et al. | Jun 2011 | A1 |
20110172774 | Varela | Jul 2011 | A1 |
20110276142 | Niemiec et al. | Nov 2011 | A1 |
20110282453 | Greenhalgh | Nov 2011 | A1 |
20110301713 | Theofilos | Dec 2011 | A1 |
20110319997 | Glerum et al. | Dec 2011 | A1 |
20120035729 | Glerum et al. | Feb 2012 | A1 |
20120059470 | Weiman | Mar 2012 | A1 |
20120059472 | Weiman | Mar 2012 | A1 |
20120109308 | Lechmann et al. | May 2012 | A1 |
20120130496 | Duffield et al. | May 2012 | A1 |
20120165945 | Hansell et al. | Jun 2012 | A1 |
20120185049 | Varela | Jul 2012 | A1 |
20120209386 | Triplett et al. | Aug 2012 | A1 |
20120215313 | Saidha et al. | Aug 2012 | A1 |
20120226357 | Varela | Sep 2012 | A1 |
20120265309 | Glerum et al. | Oct 2012 | A1 |
20120277861 | Steele et al. | Nov 2012 | A1 |
20120277870 | Wolters et al. | Nov 2012 | A1 |
20120323329 | Jimenez et al. | Dec 2012 | A1 |
20120330426 | McLaughlin et al. | Dec 2012 | A1 |
20130023993 | Weiman | Jan 2013 | A1 |
20130023994 | Glerum | Jan 2013 | A1 |
20130158663 | Miller et al. | Jun 2013 | A1 |
20130158664 | Palmatier et al. | Jun 2013 | A1 |
20130158669 | Sungarian et al. | Jun 2013 | A1 |
20130197647 | Wolters et al. | Aug 2013 | A1 |
20130211526 | Alheidt et al. | Aug 2013 | A1 |
20130274883 | McLuen et al. | Oct 2013 | A1 |
20140067071 | Weiman et al. | Mar 2014 | A1 |
20140088714 | Miller et al. | Mar 2014 | A1 |
20140163683 | Seifert et al. | Jun 2014 | A1 |
20140249628 | Weiman | Sep 2014 | A1 |
20150066145 | Rogers et al. | Mar 2015 | A1 |
20150088258 | Jimenez et al. | Mar 2015 | A1 |
20150134064 | Grotz et al. | May 2015 | A1 |
20150216676 | Shulock et al. | Aug 2015 | A1 |
20150289988 | Ashley et al. | Oct 2015 | A1 |
20150374508 | Sandul | Dec 2015 | A1 |
20160166396 | McClintock | Jun 2016 | A1 |
20160324654 | Loebl et al. | Nov 2016 | A1 |
20170100258 | Jimenez et al. | Apr 2017 | A1 |
20170119543 | Dietzel et al. | May 2017 | A1 |
Number | Date | Country |
---|---|---|
2088066 | Jan 1992 | CA |
4012622 | Jul 1991 | DE |
4327054 | Apr 1995 | DE |
0576379 | Jun 1993 | EP |
0610837 | Jul 1994 | EP |
3111896 | Jan 2017 | EP |
2794968 | Dec 2000 | FR |
2000-513263 | Oct 2000 | JP |
2006516456 | Jul 2006 | JP |
2008126085 | Jun 2008 | JP |
2015500707 | Jan 2015 | JP |
200290058 | Sep 2002 | KR |
1424826 | Sep 1988 | SU |
9201428 | Feb 1992 | WO |
9525485 | Sep 1995 | WO |
1999042062 | Aug 1999 | WO |
1999066867 | Dec 1999 | WO |
2002045625 | Jun 2002 | WO |
2004019829 | Mar 2004 | WO |
2004069033 | Aug 2004 | WO |
2006045094 | Apr 2006 | WO |
2006047587 | May 2006 | WO |
2006113080 | Oct 2006 | WO |
2008044057 | Apr 2008 | WO |
2008134515 | Nov 2008 | WO |
2009114381 | Sep 2009 | WO |
2010103344 | Sep 2010 | WO |
2012031267 | Mar 2012 | WO |
2015009793 | Jan 2015 | WO |
Number | Date | Country | |
---|---|---|---|
20200360153 A1 | Nov 2020 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14929569 | Nov 2015 | US |
Child | 16984563 | US | |
Parent | 13782724 | Mar 2013 | US |
Child | 14929569 | US |